Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche To Build On Pharma, Diagnostics Expertise For Personalized Medicine

Executive Summary

Roche sees its capabilities with both drug and diagnostics development as the key to maintaining a leadership position in targeted oncologics and personalized medicine
Advertisement

Related Content

Biopharma News, In Brief
Roche Makes Early Headway With Pharmaco-Diagnostics
Roche Seeks Diagnostics To Pair With Cancer Drugs In $3 Billion Ventana Bid
Roche CERA does not infringe EPO patents
Roche Keeps Lifecycle Management In Motion For Oncology Portfolio
Roche Sees Avastin As Oncology Backbone, Will Focus On Combinations
Herceptin sBLA (correction)
Big Pharma Seeking Simple Deals In Complex Biotech Licensing Environment
Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says
Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says
Advertisement
UsernamePublicRestriction

Register

PS047328

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel